TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
30.76
-0.62 (-1.98%)
At close: Dec 5, 2025, 4:00 PM EST
30.63
-0.13 (-0.42%)
After-hours: Dec 5, 2025, 7:13 PM EST
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $4.50 billion as of December 5, 2025. Its market cap has decreased by -4.72% in one year.
Market Cap
4.50B
Enterprise Value
4.62B
1-Year Change
-4.72%
Ranking
Category
Stock Price
$30.76
Market Cap Chart
Since December 1, 1998, TG Therapeutics's market cap has increased from $34.90M to $4.50B, an increase of 12,785.52%. That is a compound annual growth rate of 19.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 4.88B | 4.22% |
| Dec 31, 2024 | 4.69B | 81.18% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -95.45% |
| Dec 31, 2010 | 2.20M | -58.49% |
| Dec 31, 2009 | 5.30M | 783.33% |
| Dec 31, 2008 | 600.00K | -90.63% |
| Dec 31, 2007 | 6.40M | -86.18% |
| Dec 29, 2006 | 46.30M | -38.35% |
| Dec 30, 2005 | 75.10M | 181.27% |
| Dec 31, 2004 | 26.70M | -27.64% |
| Dec 31, 2003 | 36.90M | 623.53% |
| Dec 31, 2002 | 5.10M | -49.50% |
| Dec 31, 2001 | 10.10M | -49.50% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |